Preclinical CRO Market Overview
Preclinical cro market was valued at US$ 5.8 Billion in 2024 and is projected to grow at a CAGR of 7.60% to reach US$ 11.2 Billion by 2034.Preclinical CRO is the contract research organization which helps to prove the safety of new medical product and its effectiveness in live models as per FDA rules. Medical products includes drugs, devices, biologics and others. Preclinical CRO helps in providing research services like drug discovery, assay development, on contract basis. Biotechnology and Pharmaceutical companies outsource their work to CRO to reduce costs & to complete tasks in time. Preclinical activity includes, safety & pharmacological testing accompanied by bioanalysis, metabolism, pharmaceutical analysis and biomarker development. CRO are essential for biotech, pharma, and medtech industries for supporting their efforts to testing, refining, and then marketing their devices and drugs. Preclinical testing determines the starting & safe dose for first in human study and access the potential toxicity of products which includes, prescription drugs, new medical devices, and diagnostics. Clinical trials choose the CRO by its service, experience, catalog, knowledge of disease, geographical coverage, access to patients, quality management, technology, responsiveness, financial stability, staff community & proficiency, pricing, etc. CRO provides services which are related to clinical research like preclinical research which takes place before human trials to post marketing surveillance which takes place after approval of product for use. Working with CRO is extremely cost-effective way in clinical trials. There are two main CROs such as Specialty and Full service CROs. Specialty CROs tend to focus on specific area of clinical research. Full Service CROs offers services from pre-clinical testing to post marketing surveillance. CRO accelerate clinical development process in number of ways. CRO has access to large network of clinical research sites which quickly identify suitable sites for clinical trials. CROs helps in managing administrative aspects of clinical trials with freeing up company to rise focus on scientific aspects. CROs has experienced professional team who provides expert advice & guidance on every aspect of clinical research. Rising prevalence of chronic diseases has given rise in demand for clinical trials which has enhanced the Preclinical CRO Market growth
Preclinical CRO Market Dynamics
Rising prevalence of disease, research & development activities and rate of urbanization
Rising prevalence of disease, research & development activities and rate of urbanization is one of the leading factors for the Preclinical CRO Market growth. Urbanization has given rise in consumption of western food, processed food, frozen packed foods, which are unhealthy and affected the health of human being. Urbanization has given rise in disposable income which allows the individual to enhance their lifestyle, consuming high amount of red meat and animal derived food, fats & oils, sugar, sodium, alcohol intake, smoking which has affected the health and has given rise in prevalence of disease. Urbanization has caused change in diet, water pollution, air pollution due to increased number of vehicles and residential population. Urbanization has affected health condition due to emergence of infectious diseases, pollution related health conditions, inadequate house condition and consumption of poor nutrition food. Due to rapid urbanization there is rise in overcrowded settlements, inadequate housing conditions, and lack of infrastructure for water and sanitation which has caused higher risk of infectious diseases. Inadequate hygiene at fast food stalls, rising consumption of unhealthy fast food has given rise in infectious diseases. For example, Typhoid and Cholera are transmitted through water and food contaminated with human faeces which contains pathogen Urbanization has given rise in emergence and spread of arboviral disease like Zika virus, Chikungunya, Dengue which are highly adapted in urban areas. Highly connected urban areas and dense areas has become major hotspot in outbreak of disease like SARS and COVID-19. Medicinal drugs helps in preventing disease and increase immunity power and thus has become important in prevention and spread of disease. Rising diseases has given rise in research & development activities for development of new drug which has given rise in Preclinical CRO market. According to data published by United Nations in 2018, about 55% of the world’s population resided in urban areas, and it is projected that this percentage will increase over the forecast period. However, the growth in prevalence of disease, research and development activities and population in urban areas boosts the demand for Preclinical CRO market.
Restrains:
However, sponsor outsource the large number of projects to CROs but it find to be a problem with quality of control which result in failure of projects. Outsourcing projects to international brand CRO companies is expensive cost. Shortage of frontline experienced inspectors, and problem of quality control may somewhat restrain the target market growth.
Preclinical CRO Market Segmentation
The Preclinical CRO market is segmented based on service, application, end-users and region.
On the basis of service, the Preclinical CRO market is segmented into Drug Metabolism & Pharmacokinetics (DMPK) Studies, and Toxicology Testing. On the basis of application, the target market is segmented into Respiratory disease, cardiovascular disease, Infectious disease, Oncology, Diabetes, Immunological disorder, and others. On the basis of end-users, the target market is segmented into Medical Device Companies, Pharmaceutical & Biotechnology Companies, Government & Academic Institutes, and others.
Regional Insights:
On region the Preclinical CRO Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America market is estimated to witness a significantly high revenue share over the forecast period, owing to growing population, especially in countries such as Europe and Asia Pacific, and technological advancements. Moreover, rising prevalence of disease, rising research & development expenditure, presence of major key players in pharmaceutical & biotechnology industries, is anticipated to increase demand for Preclinical CRO in the region.
Report Scope:
|
Attribute |
Details |
|
Base year for estimation |
2023 |
|
Forecast period |
2024 – 2034 |
|
Market representation |
Revenue in USD Billion & CAGR from 2024 to 2034 |
|
Market Segmentation |
By Service - Drug Metabolism & Pharmacokinetics (DMPK) Studies, and Toxicology Testing By Application – Respiratory disease, Cardiovascular disease, Infectious disease, Oncology, Diabetes, Immunological disorder, and others By End-Users - Medical Device Companies, Pharmaceutical & Biotechnology Companies, Government & Academic Institutes, and others
|
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 20224 to 2034. For the purpose of this study, has segmented the Preclinical CRO Market report based on service, application, end-users and region:
Preclinical CRO Market, By Service:
- Drug Metabolism & Pharmacokinetics (DMPK) Studies
- Toxicology Testing
Preclinical CRO Market, By Application:
- Respiratory disease
- Cardiovascular disease
- Infectious disease
- Oncology
- Diabetes
- Immunological disorder
- Others
Preclinical CRO Market, By End-Users:
- Medical Device Companies
- Pharmaceutical & Biotechnology Companies
- Government & Academic Institutes
- Others
Preclinical CRO Market, By Region:
-
-
- North America
-
- U.S.
- Canada
-
- Europe
-
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
-
- Asia Pacific
-
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
-
- Latin America
-
- Brazil
- Mexico
- Rest of Latin America
-
- Middle East & Africa
-
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
-
- North America
-
Preclinical CRO Market Key Players
The key players operating the Preclinical CRO Market includes, Eurofins Scientific, Charles River Laboratories International Inc., Wuxi App Tec, Pharmaceutical Product Development LLC., FUJIFILM Holdings America Corporation, PRA Health Sciences Inc., Intertek Group Plc., Crown Bioscience & Laboratory Corporation of America Inc., PARAXEL, Medpace Inc., and others.
Recent Development:
- In December 2022, Fujifilm invests in CRO PhenoVista for access to image assay tech. Fujifilm is investing in PhenoVista Biosciences for gaining access to San Diego based CRO’s imaging based assay services. This assay services use iPSCs which help in monitoring complex intracellular function like cell health, synapse formation in individual cells, mitochondrial health that are involved in progression of disease. This investment and partnership helps in accelerating the field of iPSCs derived services that ensure more patients to get new treatment faster when they need.
Preclinical CRO Market Company Profile
- FUJIFILM Holdings America Corporation*
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Eurofins Scientific
- Charles River Laboratories International Inc.
- Wuxi App Tec
- Pharmaceutical Product Development LLC.
- PRA Health Sciences Inc.
- Intertek Group Plc.
- Crown Bioscience & Laboratory Corporation of America Inc.
- PARAXEL
- Medpace Inc.
“*” marked represents similar segmentation in other categories in the respective section
Preclinical CRO Market Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
- Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Thickness Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
- Market Purview
- Executive Summary
- Key Findings—Global Outlook for medical carts Strategies
- Key Questions this Study will Answer
- Market Snippet, By Service
- Market Snippet, By Application
- Market Snippet, By End-Users
- Market Snippet, By Region
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restrains
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Preclinical CRO Market, By Service
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2022 – 2032
- Y-o-Y Growth Analysis (%), 2022 – 2032
- Segment Trends
- Drug Metabolism & Pharmacokinetics (DMPK) Studies
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Toxicology Testing
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Overview
- Preclinical CRO Market, By Application, 2022 – 2032, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2022 – 2032
- Y-o-Y Growth Analysis (%), 2022 – 2032
- Segment Trends
- Respiratory disease
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Cardiovascular disease
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Infectious disease
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Oncology
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Diabetes
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Immunological disorder
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Others
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Overview
- Preclinical CRO Market, By End-Users, 2022 – 2032, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2022 – 2032
- Y-o-Y Growth Analysis (%), 2022 – 2032
- Segment Trends
- Medical Device Companies
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Pharmaceutical & Biotechnology Companies
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Government & Academic Institutes
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Others
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Overview
- Preclinical CRO Market, By Region, 2022 – 2032, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2022 – 2032
- Y-o-Y Growth Analysis (%), 2022 – 2032
- Regional Trends
- North America
- Market Size and Forecast (US$ Bn), By Service, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Application, 2022 – 2032
- Market Size and Forecast (US$ Bn), By End-Users, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Bn), By Service, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Application, 2022 – 2032
- Market Size and Forecast (US$ Bn), By End-Users, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
- UK
- France
- Germany
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Bn), By Service, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Application, 2022 – 2032
- Market Size and Forecast (US$ Bn), By End-Users, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
- India
- Japan
- South Korea
- China
- Rest of Asia Pacific
- Overview
-
- Latin America
- Market Size and Forecast (US$ Bn), By Service, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Application, 2022 – 2032
- Market Size and Forecast (US$ Bn), By End-Users, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
- Latin America
-
-
-
- Brazil
- Mexico
- Rest of Latin America
-
- Middle East & Africa
- Market Size and Forecast (US$ Bn), By Service, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Application, 2022 – 2032
- Market Size and Forecast (US$ Bn), By End-Users, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
-
-
-
-
- GCC
- Israel
- South Africa
- Rest of Middle East
-
-
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
- Eurofins Scientific
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Charles River Laboratories International Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Wuxi App Tec
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Pharmaceutical Product Development LLC.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- FUJIFILM Holdings America Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- PRA Health Sciences Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Intertek Group Plc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Crown Bioscience & Laboratory Corporation of America Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- PARAXEL
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Medpace Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- The Last Word
- Future Impact
- About Us
- Contact
FAQs
The Preclinical CRO Market is segmented into service, application, end-users and region.
Preclinical CRO Market is driven by factors like rising prevalence of disease, research & development activities and rate of urbanization.
By region, the Preclinical CRO market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America market is estimated to witness a significantly high revenue share over the forecast period, owing to growing population, especially in countries such as Europe and Asia Pacific, and technological advancements.
The key players operating the Preclinical CRO Market includes, Eurofins Scientific, Charles River Laboratories International Inc., Wuxi App Tec, Pharmaceutical Product Development LLC., FUJIFILM Holdings America Corporation, PRA Health Sciences Inc., Intertek Group Plc., Crown Bioscience & Laboratory Corporation of America. Inc., PARAXEL, Medpace Inc., and others.